NL7005398A - - Google Patents

Info

Publication number
NL7005398A
NL7005398A NL7005398A NL7005398A NL7005398A NL 7005398 A NL7005398 A NL 7005398A NL 7005398 A NL7005398 A NL 7005398A NL 7005398 A NL7005398 A NL 7005398A NL 7005398 A NL7005398 A NL 7005398A
Authority
NL
Netherlands
Application number
NL7005398A
Other versions
NL146813B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2990669A external-priority patent/JPS4826758B1/ja
Priority claimed from JP3295669A external-priority patent/JPS4834748B1/ja
Priority claimed from JP3295569A external-priority patent/JPS493995B1/ja
Priority claimed from JP3720769A external-priority patent/JPS493996B1/ja
Application filed filed Critical
Publication of NL7005398A publication Critical patent/NL7005398A/xx
Publication of NL146813B publication Critical patent/NL146813B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/26—Preparation from compounds already containing the benzodiazepine skeleton
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL707005398A 1969-04-16 1970-04-15 Werkwijze voor het bereiden van een 1-cycloalkyl-alkyl-7-halogeen-1,3-dihydro-5-fenyl-2h-1,4-benzodiazepine-2-on-derivaat met sedatieve, spierverslappende en anticonvulsieve werking en voor het bereiden van therapeutische preparaten alsmede de verkregen gevormde preparaten. NL146813B (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2990669A JPS4826758B1 (enrdf_load_stackoverflow) 1969-04-16 1969-04-16
JP3295669A JPS4834748B1 (enrdf_load_stackoverflow) 1969-04-28 1969-04-28
JP3295569A JPS493995B1 (enrdf_load_stackoverflow) 1969-04-28 1969-04-28
JP3720769A JPS493996B1 (enrdf_load_stackoverflow) 1969-05-14 1969-05-14

Publications (2)

Publication Number Publication Date
NL7005398A true NL7005398A (enrdf_load_stackoverflow) 1970-10-20
NL146813B NL146813B (nl) 1975-08-15

Family

ID=27459141

Family Applications (1)

Application Number Title Priority Date Filing Date
NL707005398A NL146813B (nl) 1969-04-16 1970-04-15 Werkwijze voor het bereiden van een 1-cycloalkyl-alkyl-7-halogeen-1,3-dihydro-5-fenyl-2h-1,4-benzodiazepine-2-on-derivaat met sedatieve, spierverslappende en anticonvulsieve werking en voor het bereiden van therapeutische preparaten alsmede de verkregen gevormde preparaten.

Country Status (6)

Country Link
CA (1) CA969941A (enrdf_load_stackoverflow)
DE (1) DE2016385C3 (enrdf_load_stackoverflow)
DK (1) DK137330B (enrdf_load_stackoverflow)
FR (1) FR2042330B1 (enrdf_load_stackoverflow)
GB (1) GB1283434A (enrdf_load_stackoverflow)
NL (1) NL146813B (enrdf_load_stackoverflow)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131731C (enrdf_load_stackoverflow) * 1965-12-09

Also Published As

Publication number Publication date
DE2016385A1 (de) 1971-02-18
DE2016385C3 (de) 1980-09-18
NL146813B (nl) 1975-08-15
FR2042330B1 (enrdf_load_stackoverflow) 1974-04-12
CA969941A (en) 1975-06-24
DK137330B (da) 1978-02-20
FR2042330A1 (enrdf_load_stackoverflow) 1971-02-12
DK137330C (enrdf_load_stackoverflow) 1978-07-17
GB1283434A (en) 1972-07-26
DE2016385B2 (de) 1980-01-10

Similar Documents

Publication Publication Date Title
AU2270770A (enrdf_load_stackoverflow)
AU465452B2 (enrdf_load_stackoverflow)
AU429630B2 (enrdf_load_stackoverflow)
AU450150B2 (enrdf_load_stackoverflow)
AU442375B2 (enrdf_load_stackoverflow)
AU2355770A (enrdf_load_stackoverflow)
AU470301B1 (enrdf_load_stackoverflow)
AU5113869A (enrdf_load_stackoverflow)
AU442535B2 (enrdf_load_stackoverflow)
AU417208B2 (enrdf_load_stackoverflow)
AU428131B2 (enrdf_load_stackoverflow)
AU428074B2 (enrdf_load_stackoverflow)
AU410358B2 (enrdf_load_stackoverflow)
AU438128B2 (enrdf_load_stackoverflow)
AU428129B2 (enrdf_load_stackoverflow)
AU442285B2 (enrdf_load_stackoverflow)
AU442322B2 (enrdf_load_stackoverflow)
AU442357B2 (enrdf_load_stackoverflow)
AU425297B2 (enrdf_load_stackoverflow)
AU442380B2 (enrdf_load_stackoverflow)
AU442463B2 (enrdf_load_stackoverflow)
AU442554B2 (enrdf_load_stackoverflow)
AU442538B2 (enrdf_load_stackoverflow)
AU4540468A (enrdf_load_stackoverflow)
AU5228269A (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
NL80 Abbreviated name of patent owner mentioned of already nullified patent

Owner name: SUMITOMO

V4 Lapsed because of reaching the maxim lifetime of a patent